Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase

Virology

Volumn 219, Issue 1, 1996, Pages 228-236

  Welker, Reinhold ^a,b   Kottler, Hubert ^a   Kalbitzer, Hans Robert ^c   Kräusslich, Hans Georg ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; PROTEINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES;

EID: 0029975546     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0240     Document Type: Article

References (52)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 59, 284-291.
2. Ahmad, N., and Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR Science 242, 1481-1485.
3. Aiken, C., and Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol. 69, 5048-5056.
4. Aiken, C., Konner, J., Landau, N., Lenburg, M., and Trono, D. (1994). Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
5. Allan, J., Coligan, J., Lee, T., McLane, M., Kanki, P., Groopman, J., and Essex, M. (1985). A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810-813.
6. Baur, A., Sawai, E., Dazin, P., Fantl, W., Cheng-Mayer, C., and Peterlin, B. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
7. Bodeus, M., Marie-Cardine, A., Bougeret, C., Ramos-Morales, F., and Benarous, R (1995). In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J Gen. Virol. 76, 1337-1344.
8. Burnette, B., Yu, G., and Felsted, R. L. (1993). Phosphorylation of HIV 1 gag proteins by protein kinase C. J. Biol. Chem. 268, 8698-8703.
9. Chowers, M., Spina, C., Kwoh, T., Fitch, N., Richman, D., and Guatelli, J (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
10. Cullen, B. R. (1994). The role of Nef in the replication cycle of human and simian immunodeficiency viruses. Virology 205, 1-6.
11. deRonde, A., Klaver, B., Keulin, W., Smit, L., and Goudsmit, J. (1992). Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology 188, 391-395.
12. Dorfman, T., Mammano, F., Haseltine, W. A., and Göttlinger, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol. 68, 1689-1696.
13. Fleissner, E. (1971). Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. J. Virol. 8, 778-785.
14. Franchini, G., Robert-Guroff, M., Ghrayeb, J., Chang, N., and Wong-Staal, F. (1986). Cytoplasmic localization of the HTLV III 3′ orf in cultured T cells. Virology 155, 593-599.
15. Freund, J., Kellner, R., Houthaeve, T., and Kalbitzer, H. (1994a). Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 221, 811-819.
16. Freund, J., Kellner, R., Konvalinka, J., Wolber, V., Kräusslich, H.-G., and Kalbitzer, H. R. (1994b). A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 bythe viral protease. Eur. J. Biochem. 223, 589-593.
17. Gaedigk-Nitschko, K., Schön, A., Wachinger, G., Erfle, V., and Kohleisen, B. (1995). Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett. 357, 275-278.
18. Gallay, P., Swingler, S., Aiken, C., and Trono, D. (1995a). HIV-1 infection of nondividing cells: C-terminal phosphorylation of the viral matrix protein is a key regulator. Cell 80, 379-388.
19. Gallay, P., Swingler, S., Song, G., Bushman, F., and Trono, D. (1995b). HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83, 569-579.
20. Garcia, J. V., and Miller, A. D. (1991). Serine phosphorylation independent downregulation of cell-surface CD4 by Nef. Nature (London) 350, 508-511.
21. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D., and Greene, W. C. (1995). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112-4121.
22. Greenway, A., Azad, A., and McPhee, D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850.
23. Guy, B., Riviere, Y., Dott, K., Regnault, A., and Kieny, M. P. (1990). Mutational analysis of the HIV Nef protein. Virology 176, 413-425.
24. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R., and Greene, W. C. (1989). Nef protein of human immunodeficiency virus type 1: Evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad. Sci. USA 86, 9549-9553.
25. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985). Infection of HTLV-III/LAV in HTLV-I carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
26. Huang, Y., Zhang, L., and Ho, D. D. (1995). Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69, 93-100.
27. Jacks, T. (1990). Translational suppression in gene expression in retroviruses and retrotransposons. Curr. Top. Microbiol. Immunol. 157, 93-124.
28. Jamieson, B. D., Aldrovandi, G. M., Planelles, V., Jowett, J. B., Gao, L., Bloch, L. M., Chen, I. S., and Zack, J. A. (1994). Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68, 3478-3485.
29. Kaminchik, J., Bashan, N., Itach, A., Sarver, N., Gorecki, M., and Panet, A. (1991). Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J. Virol. 65, 583-588.
30. Kestler, H., Ringler, D., Mori, K., Panicali, D., Sehgal, P., Daniel, M., and Desrosiers, R. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
31. Kim, S., Ikeuchi, K., Byrn, R., Groopman, J., and Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 9544-9548.
32. Kirchhoff, F., Greenough, T., Brettler, D., Sullivan, J., and Desrosiers, R. (1995). Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J Med. 332, 228-323.
33. Konvalinka, J., Litterst, M. A., Welker, R., Kottler, H., Rippmann, F., Heuser, A.-M., and Kräusslich, H.-G. (1995). An active site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69, 7180-7186.
34. Kräusslich, H.-G., and Welker, R. (1996). Intracellular transport of retroviral capsid components. Curr. Top. Microbiol. Immunol. 214, in press.
35. Mergener, K., Fäcke, M., Welker, R., Brinkmann, V., Gelderblom, H., and Kräusslich, H.-G. (1992). Analysis of HIV-1 particle formation using transient expression of subviral constructs in mammalian cells. Virol-ogy 186, 25-39.
36. Miller, M., Warmerdam, M., Gaston, I., Greene, W., and Feinberg, M. (1994). The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
37. Miller, M., Warmerdam, M., Page, K., Feinberg, M., and Greene, W. (1995). Expression of human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69, 579-584.
38. Niederman, T. M., Hastings, W. R., and Ratner, L. (1993). Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. Virology 197, 420-425.
39. Niederman, T., Thielan, B., and Ratner, L. (1989). Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc. Natl. Acad. Sci. USA 86, 1128-1132.
40. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E., and Krohn, K. J. (1994). Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139, 365-378.
41. Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., Lambert, R. W., Merrett, J. H., Mills, J. S., Parkes, K. E. B., Redshaw, S., Ritchie, A. J., Taylor, D. L., Thomas, G. J., and Machin, P. J. (1990). Rational design of peptide-based HIV-proteinase inhibitors. Science 248, 358-361.
42. - phenotype in HIV-1 and HIV-2. Virology 213, 158-168.
43. Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of src kinases and are required for the enhanced growth of Nef+ viruses but not for downregulation of CD4. EMBO J. 14, 484-491.
44. Salahuddin, S. Z., Markham, P. D., Wong-Staal, F., Franchini, G., Kalyanaraman, V. S., and Gallo, R. C. (1983). Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129, 51-64.
45. Sawai, E., Baur, A., Struble, H., Peterlin, B. M., Levy, J., and Cheng-Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1539-1543.
46. Sawai, E. T., Baur, A. S., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1995). A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with cellular serine kinase activity. J Biol. Chem. 270, 15307-15314.
47. Schwartz, O., Marechal, V., Danos, O., and Heard, J. (1995). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059.
48. Spina, C., Kwoh, T., Chowers, M., Guatelli, J., and Richman, D. (1994). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123.
49. Stevenson, M. (1996). Portals of entry: Uncovering HIV nuclear transport pathways. Trends Cell Biol. 6, 9-15.
50. Terwilliger, E., Langhoff, E., Gabuzda, D., Zazopopulos, E., and Haseltine, W. (1986). Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 88, 10971-10975.
51. Yu, G., and Felsted, R. (1992). Effect of myristoylation on p27 Nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187, 46-55.
52. Yu, G., Shen, F. S., Sturch, S., Aquino, A., Glazer, R. I., and Felsted, R. L. (1995). Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J. Biol. Chem. 270, 4792-4796.